Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001797030 | SCV002038558 | uncertain significance | Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome | 2021-06-09 | criteria provided, single submitter | clinical testing | The TRIO c.2105C>T (p.Ser702Leu) variant is a missense variant. A literature search was conducted for the gene, cDNA change, and amino acid change. No publications were identified through this search. This variant is reported at a frequency of 0.000065 in the European (non-Finnish) population of the Genome Aggregation Database (version 2.1.1), but this frequency is based on one allele only in a region of good sequencing coverage, so the variant is presumed rare. In silico algorithms differ in their predictions for this variant, which is not located in a known protein domain. Based on the limited available evidence and the application of ACMG criteria, the p.Ser702Leu variant is classified as a variant of uncertain significance for TRIO-related intellectual disability. |
Gene |
RCV004728821 | SCV005333304 | uncertain significance | not provided | 2024-02-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 36937954) |
Clinical Laboratory Sciences Program |
RCV003154196 | SCV003803003 | pathogenic | Developmental delay | no assertion criteria provided | clinical testing |